Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination

SIMPLE SUMMARY: Cancer patients are considered a high-risk group for infectious diseases including COVID-19. The protective effects of vaccination are unclear in oncologic patients, as well as their duration. In this study antibody, T-cell and myeloid cell immunity were evaluated in three cohorts of...

Descripción completa

Detalles Bibliográficos
Autores principales: Echaide, Miriam, Labiano, Ibone, Delgado, Marina, Fernández de Lascoiti, Angela, Ochoa, Patricia, Garnica, Maider, Ramos, Pablo, Chocarro, Luisa, Fernández, Leticia, Arasanz, Hugo, Bocanegra, Ana, Blanco, Ester, Piñeiro-Hermida, Sergio, Morente, Pilar, Vera, Ruth, Alsina, Maria, Escors, David, Kochan, Grazyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496802/
https://www.ncbi.nlm.nih.gov/pubmed/36139625
http://dx.doi.org/10.3390/cancers14184464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496802/
https://www.ncbi.nlm.nih.gov/pubmed/36139625
http://dx.doi.org/10.3390/cancers14184464

Ejemplares similares